EMA published meeting highlights from the Committee for Veterinary Medicinal Products (CVMP) for 10–12 March 2026. The agency says the meeting was followed by EMA Veterinary Medicines Info Day 2026 on 12–13 March, providing stakeholders with updates on regulatory policy and scientific and legislative developments in the veterinary domain.
This is useful global-watch material because it broadens the usual human-medicines focus. Veterinary regulation is part of the same wider ecosystem of safety oversight, data expectations, and evolving regulatory practice. That framing is an inference, but it is supported by EMA’s positioning of CVMP and the associated information day.
For readers building a broad view of pharmacovigilance, the veterinary side of regulation is worth watching, especially where trends in transparency, policy updates, and committee processes mirror larger regulatory patterns.
0 Comments